Delivery Order SPE2DR25D1100-SPE2DR26FDB8B
Award Date 1/26/26
Potential Completion Date 2/17/26
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 23, 2026, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of February 13, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a $3,486.67 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 27, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting the contractor's ability to compete in open...
- The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 15, 2026, with an ultimate completion date of February 6, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded under full and open competition. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 5, 2026, with a ceiling value of $6,973.34 and ultimate completion date of January 27, 2026. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication, with a ceiling value of $4,987.78 and an ultimate completion date of May 12, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract was performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/ml auto-injector units with a contract ceiling value of $6,165.34. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 2, 2025, with completion expected by December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. Benlysta is a biologic medication used to treat systemic lupus erythematosus, and this award represents a specific product delivery under the...
- The Defense Logistics Agency awarded a $9,248.01 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used to treat systemic lupus erythematosus and other...